Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0376358 (
prostate cancer
)
59,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
As a latent transcription factor, nuclear factor kappaB (NF-kappaB) translocates from the cytoplasm into the nucleus upon stimulation and mediates the expression of genes that are important in immunity, inflammation, and development. However, little is known about how it is regulated inside the nucleus. By a two-hybrid approach, we identify a prefoldin-like protein,
ubiquitously expressed transcript
(
UXT
), that is expressed predominantly and interacts specifically with NF-kappaB inside the nucleus. RNA interference knockdown of
UXT
leads to impaired NF-kappaB activity and dramatically attenuates the expression of NF-kappaB-dependent genes. This interference also sensitizes cells to apoptosis by tumor necrosis factor-alpha. Furthermore,
UXT
forms a dynamic complex with NF-kappaB and is recruited to the NF-kappaB enhanceosome upon stimulation. Interestingly, the
UXT protein
level correlates with constitutive NF-kappaB activity in human
prostate cancer
cell lines. The presence of NF-kappaB within the nucleus of stimulated or constitutively active cells is considerably diminished with decreased endogenous
UXT
levels. Our results reveal that
UXT
is an integral component of the NF-kappaB enhanceosome and is essential for its nuclear function, which uncovers a new mechanism of NF-kappaB regulation.
...
PMID:UXT is a novel and essential cofactor in the NF-kappaB transcriptional enhanceosome. 1762 Apr 5
The EVI1 transcriptional repressor is critical to the normal development of a variety of tissues and participates in the progression of acute myeloid leukaemias. The repressor domain (Rp) was used to screen an adult human kidney yeast two-hybrid library and a novel binding partner designated
ubiquitously expressed transcript
(
UXT
) was isolated. Enforced expression of
UXT
in Evi1-expressing Rat1 fibroblasts suppresses cell transformation and
UXT
may therefore be a negative regulator of Evi1 biological activity. The Rp-binding site for
UXT
was determined and non-
UXT
-binding Evi1 mutants (Evi1Delta706-707) were developed which retain the ability to bind the corepressor mCtBP2. Evi1Delta706-707 transforms Rat1 fibroblasts, showing that the interaction is not essential for Evi1-mediated cell transformation. However, Evi1Delta706-707 produces an increased proportion of large colonies relative to wild-type, showing that endogenous
UXT
has an inhibitory effect on Evi1 biological activity. Exogenous
UXT
still suppresses Evi1Delta706-707-mediated cell transformation, indicating that it inhibits cell proliferation and/or survival by both Evi1-dependent and Evi1-independent mechanisms. These observations are consistent with the growth-suppressive function attributed to
UXT
in human
prostate cancer
. Our results show that
UXT
suppresses cell transformation and might mediate this function by interaction and inhibition of the biological activity of cell proliferation and survival stimulatory factors like Evi1.
...
PMID:UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation. 1763 84
Ubiquitously-expressed, prefoldin-like chaperone (UXT) also called Androgen Receptor Trapped clone-27 (ART-27) is widely expressed in human tissues. Our previous studies showed that UXT regulates transcription repression including androgen receptor (AR) signaling in
prostate cancer
. Here we analyzed a tissue microarray consisting of normal prostate, benign prostatic hyperplasia, high grade prostatic intraepithelial neoplasia (HGPIN) and primary
prostate cancer
cases for
UXT protein
expression. We found that HGPIN and malignant tumors have significantly decreased UXT expression compared to the normal prostate. Loss of UXT expression in primary
prostate cancer
is positively associated with high Gleason grade and poor relapse-free survival. We engineered prostate-specific
Uxt
KO
mice that developed a hyperplastic phenotype with apparent prostate secretion fluid blockage as well as PIN by 4-6 months. Doubly mutant
Uxt
KO
/
Pten
KO
mice developed a more aggressive PIN phenotype. UXT depletion in
prostate cancer
cells also increased retroelements expression, including LINE-1 and Alu. Consistent with this finding
Uxt
KO
mice have increased LINE-1 protein levels in the prostate compared to control mice. In addition, cancer cells with UXT depletion have increased retrotransposition activity and accumulated DNA damage. Our findings demonstrate that loss of UXT is an early event during
prostate cancer
progression, which may contribute to genome instability.
...
PMID:Prostate-specific loss of UXT promotes cancer progression. 3077 73